Correlation Between MAIA Biotechnology and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on MAIA Biotechnology and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Crinetics Pharmaceuticals.
Diversification Opportunities for MAIA Biotechnology and Crinetics Pharmaceuticals
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between MAIA and Crinetics is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Crinetics Pharmaceuticals
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 26.01 times less return on investment than Crinetics Pharmaceuticals. In addition to that, MAIA Biotechnology is 1.42 times more volatile than Crinetics Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.05 per unit of volatility. If you would invest 1,997 in Crinetics Pharmaceuticals on November 5, 2024 and sell it today you would earn a total of 2,033 from holding Crinetics Pharmaceuticals or generate 101.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MAIA Biotechnology vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| MAIA Biotechnology |
| Crinetics Pharmaceuticals |
MAIA Biotechnology and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Crinetics Pharmaceuticals
The main advantage of trading using opposite MAIA Biotechnology and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |